Lexapro News

Company launches app to document experiences with antidepressants

November 17th, 2015

A crowdsourced drug review startup company called Iodine has released an app to document patient experiences with antidepressants. The app is called “Start,” and it’s designed to track and log a patient’s usage of antidepressants as well as how they’re feeling, antidepressant side effects they’ve experienced, perceived drug efficacy and other factors. More »

New study strengthen link between autism and antidepressant use during pregnancy

May 13th, 2014

Taking selective serotonin reuptake inhibitor antidepressants (SSRIs) during pregnancy can increase the risk of autism, according to a study of nearly 1,000 mother-child pairs conducted at the Bloomberg School of Public Health. The greatest connection between SSRIs and prenatal autism occurred in boys, where male children born to mothers who used SSRIs during pregnancy were three times as likely to be autistic. More »

SSRIs tied to increased pulmonary hypertension in newborns

February 17th, 2014

A new study published in the BMJ has tied late pregnancy use of selective serotonin reuptake inhibitor antidepressants (SSRIs) to an increased risk of persistent pulmonary hypertension in newborns. Well known SSRI antidepressants include Paxil, Celexa, Lexapro and Zoloft. More »

Doctors push alternative to antidepressants during pregnancy

September 3rd, 2013

Doctors are increasingly recommending alternatives to antidepressant drugs for pregnant women. Selective serotonin reuptake inhibitor antidepressants (SSRIs) such as Zoloft, Celexa and Lexapro are among the most-prescribed drugs in the world, but carry significant birth defects risks. More »

Mother leads quest for more studies on SSRIs, autism

July 26th, 2013

A mother of two autistic children is leading a mission for more studies on the pharmaceutical causes of autism, including selective serotonin reuptake inhibitor antidepressants (SSRIs), such as Zoloft, Lexapro and Celexa. Jill Escher began her independent research to discover why two out of three of her children were autistic. More »

SSRI antidepressant linked to serious infection

June 5th, 2013

Fluoxetine, a selective serotonin reuptake inhibitor antidepressant (SSRI), has been found to double the risk of clostridium difficile infection (CDI), according to new research. CDI can require hospitalization and result in the transfer of other infections or disease. More »

January is National Birth Defects Prevention Month

January 16th, 2013

January is National Birth Defects Prevention Month in the United States, a month dedicated to raising awareness to the causes and cures for birth defects. One key aspect of National Birth Defects Prevention Month is educating women about the risks of birth defects associated with medications. More »

Canada certifies class action Paxil birth defects lawsuit

December 6th, 2012

A Canadian woman’s Paxil lawsuit has been certified as a class action, the first in Canada for birth defects related to antidepressants. Faith Gibson alleges that drug manufacturer GlaxoSmithKline failed to warn patients and doctors that its antidepressant Paxil could increase the risks of severe birth defects after her daughter was born with a hole in her heart. More »

Celexa, Lexapro linked to birth defects in new study

November 16th, 2012

Antidepressants such as Celexa and Lexapro have been linked to an increased risk of serious birth defects, according to a new study published in the journal Human Reproduction. The study encompassed all antidepressants in the same class as Celexa and Lexapro, known as selective serotonin reuptake inhibitors (SSRIs). More »

Drug maker receives approval for generic Lexapro

September 21st, 2012

Indian drug maker Lupin Pharmaceuticals has received final approval from the Food and Drug Administration to sell its generic form of the antidepressant Lexapro in the U.S. The company is among the first to receive approval. More »

I am currently represented by an attorney
*Required fields